2,4-Dihydroxybenzylamine: A specific inhibitor of glutathione reductase
- 15 January 1991
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (2) , 185-190
- https://doi.org/10.1016/0006-2952(91)90475-k
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (11210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosoureaBiochemical Pharmacology, 1988
- Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymesBiochemical Pharmacology, 1986
- FAD analogues as prosthetic groups of human glutathione reductaseEuropean Journal of Biochemistry, 1985
- Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamineBiochemical Pharmacology, 1985
- Novel substrates for tyrosinase serve as precursors of 6-hydroxydopamine and 6-hydroxydopaBiochemistry, 1983
- Selective Modification of Glutathione MetabolismScience, 1983
- 3,4-Dihydroxybenzylamine: An Improved Dopamine Analog Cytotoxic for Melanoma Cells in Part Through Oxidation Products Inhibitory to DNA PolymeraseJournal of Investigative Dermatology, 1983
- Glutathione reductase from yeast. Differential reactivity of the nascent thiols in two-electron reduced enzyme and properties of a monoalkylated derivativeBiochemistry, 1981
- Inactivation of glutathione reductase by 2-chloroethyl nitrosourea-derived isocyanatesBiochemical and Biophysical Research Communications, 1978
- STRUCTURAL MODELS OF CORTIN COMPOUNDS IN THE NAPHTHALENE SERIESThe Journal of Organic Chemistry, 1941